SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

NCT06384482 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma

Interventions

DRUG: SNC115 injection

Sponsor

Shanghai Simnova Biotechnology Co.,Ltd.

Collaborators

[object Object]